Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances in the EU: the outcomes of the ReDNet project

Ornella Corazza, Sulaf Assi, Pierluigi Simonato, John Corkery, Francesco Saverio Bersani, Zsolt Demetrovics, Jacqueline L. Stair, Suzanne Fergus, Cinzia Pezzolesi, Manuela Pasinetti, Paolo Deluca, Colin Drummond, Zoe Davey, Ursula Blaszko, Jacek Moskalewicz, Barbara Mervó, Lucia Di Furia, Maggi Farre, Liv Flesland, Agnieszka Pisarska, Harry L. Shapiro, Holger Siemann, Arvid Skutle, Elias Sferrazza, Marta Torrens, F. Sambola, Peer van der Kreeft, Norbert Scherbaum, Fabrizio Schifano · 2013 · Human Psychopharmacology Clinical and Experimental

Summary. The ReDNet project monitored online drug markets across eight European countries to identify novel psychoactive substances and combat their rapid spread. Researchers tracked over 650 NPS products through websites and forums, then developed prevention messages delivered via websites, SMS, social media, and smartphone apps. The project demonstrated that web-monitoring combined with technology-based interventions effectively reaches young people and informs policymakers about emerging drug threats.

Read the original

Cite this article

Corazza, O., Assi, S., Simonato, P., Corkery, J., Bersani, F. S., Demetrovics, Z., Stair, J. L., Fergus, S., Pezzolesi, C., Pasinetti, M., Deluca, P., Drummond, C., Davey, Z., Blaszko, U., Moskalewicz, J., Mervó, B., Furia, L. D., Farre, M., Flesland, L., . . . Schifano, F.. (2013). Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances in the EU: the outcomes of the ReDNet project. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/hup.2299

@article{corazza-2013-promoting-innovation-excellence-face-rapid,
  title   = {Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances in the EU: the outcomes of the ReDNet project},
  author  = {Ornella Corazza and Sulaf Assi and Pierluigi Simonato and John Corkery and Francesco Saverio Bersani and Zsolt Demetrovics and Jacqueline L. Stair and Suzanne Fergus and Cinzia Pezzolesi and Manuela Pasinetti and Paolo Deluca and Colin Drummond and Zoe Davey and Ursula Blaszko and Jacek Moskalewicz and Barbara Mervó and Lucia Di Furia and Maggi Farre and Liv Flesland and Agnieszka Pisarska and Harry L. Shapiro and Holger Siemann and Arvid Skutle and Elias Sferrazza and Marta Torrens and F. Sambola and Peer van der Kreeft and Norbert Scherbaum and Fabrizio Schifano},
  journal = {Human Psychopharmacology Clinical and Experimental},
  year    = {2013},
  doi     = {10.1002/hup.2299},
  url     = {https://doi.org/10.1002/hup.2299}
}

TY  - JOUR
TI  - Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances in the EU: the outcomes of the ReDNet project
AU  - Ornella Corazza
AU  - Sulaf Assi
AU  - Pierluigi Simonato
AU  - John Corkery
AU  - Francesco Saverio Bersani
AU  - Zsolt Demetrovics
AU  - Jacqueline L. Stair
AU  - Suzanne Fergus
AU  - Cinzia Pezzolesi
AU  - Manuela Pasinetti
AU  - Paolo Deluca
AU  - Colin Drummond
AU  - Zoe Davey
AU  - Ursula Blaszko
AU  - Jacek Moskalewicz
AU  - Barbara Mervó
AU  - Lucia Di Furia
AU  - Maggi Farre
AU  - Liv Flesland
AU  - Agnieszka Pisarska
AU  - Harry L. Shapiro
AU  - Holger Siemann
AU  - Arvid Skutle
AU  - Elias Sferrazza
AU  - Marta Torrens
AU  - F. Sambola
AU  - Peer van der Kreeft
AU  - Norbert Scherbaum
AU  - Fabrizio Schifano
JO  - Human Psychopharmacology Clinical and Experimental
PY  - 2013
DO  - 10.1002/hup.2299
UR  - https://doi.org/10.1002/hup.2299
ER  -

Details

DOI: 10.1002/hup.2299
Countries: United Kingdom, Norway, Belgium, Germany, Hungary, Poland, Italy, Spain
Regions: Europe
Categories: policy, general-innovation
Added: 2026-04-28